Skip to content

META English logo

Main menu
    • About us
      • Vision, mission and values
      • Diversity, equity & inclusion
      • Executive Leadership Team
      • Global Leaders
      • Board of Directors
      • Our leaders
    • Environmental, social & governance
    • Policies & positions
    • Suppliers
    • Media
    • Press releases
    • Women’s Health Accelerator
    • Rahet Bally x Organon
    • Investor relations overview
    • SEC filings
  • Join our team

Contact Us

Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA
  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom
  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

What can we help you find?

Search for:
Her story

Navigating life with Crohn’s disease

Founder Stefanie Fish Shares Her Daughter’s Story

September 22, 2021

Share this article

Stefanie Fish, Associate Vice President and her daughter

Here’s her story in Stefanie’s words

I remember my daughter as a healthy child, hardly ever sick. But around age 12, everything changed. Suddenly, She wasn’t just sick – she was severely ill.

It took about a year for doctors to figure out my daughter had Crohn’s disease. She was fearful of doctors, and became good at hiding her symptoms. We received and later ruled out several diagnoses. In the meantime, she was getting more and more ill.

Finding a diagnosis

During her first hospital stay, doctors finally discovered her Crohn’s disease. A team of doctors listened to our pleas and admitted my daughter for her stomach pains; their battery of tests then revealed an intestinal virus seen only in extremely immunocompromised patients. Then a colonoscopy confirmed Crohn’s disease.

By the time we realized the extent of her illness, her immune system had all but shut down – but not before it had severely and permanently damaged her colon.

Managing the disease

My daughter’s life with Crohn’s disease has been difficult. She has regular flare ups that have to be managed, sometimes with trips to the hospital. The pain can be challenging and the flare ups require a liquid diet, sometimes for weeks or months at a time to help her gastrointestinal system heal.

My daughter has learned what foods she can eat and which she can’t – popcorn and steak are huge no’s. Sometimes we never know what brought on a flare. She’s sadly used to having them at the most inopportune times, like vacation and summer camp. Life with Crohn’s means sometimes visiting doctors out-of-state. Over the years, she’s missed many days of of school, and though she proudly graduated high school this year, she feels her disease undermined some of the things she could have experienced. That’s tough to think about.

A positive attitude

With her positive, inspiring attitude, you’d never know how tough life has been for her.

I try not to remember that lost year when she suffered without a clear diagnosis. She is considered immunocompromised and must manage that.  With the COVID-19 pandemic, she must make tough decisions like whether to be virtual for her first year of college as a molecular biology major.

My daughter makes the best out of her disease. When she’s pain-free, she appreciates her life in a way few people do. And though her Crohn’s will never go away, through it all she has found a village of loved ones and friends who support her. She’s come so far. There’s nothing more beautiful than that.

META English logo

Company

  • About us
  • Our leaders
  • Environmental, social & governance

Resources

  • Patient resources
  • Investor relations
  • Media

Contact us

  • Contact Us
  • Contact information
  • Global locations
  • Forward-Looking Statement
  • cookie policy
  • Privacy
  • Terms of Use
  • Sitemap
© 2025 Organon group of companies. All rights reserved. ORGANON and the ORGANON Logo are trademarks of the Organon group of companies.

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

This news release of Organon (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov Opens a new window ).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept